Literature DB >> 20731557

Echinacea and trypanasomatid parasite interactions: growth-inhibitory and anti-inflammatory effects of Echinacea.

Judith Canlas1, James B Hudson, Manju Sharma, Devki Nandan.   

Abstract

CONTEXT/
OBJECTIVE: Herbal preparations derived from various species and parts of Echinacea (Asteraceae) have been advocated for various medical applications, as a result of the many antimicrobial and immunomodulatory activities attributed to them.
MATERIALS AND METHODS: In order to investigate their effects on parasites, four preparations of Echinacea, with distinct chemical compositions, were evaluated for growth inhibition of three species of trypanosomatids: Leishmania donovani, Leishmania major, and Trypanosoma brucei. In addition one Echinacea preparation was tested for anti-inflammatory activity in cell culture models designed to measure pro-inflammatory cytokines induced by L. donovani. RESULTS AND DISCUSSION: All Echinacea preparations inhibited growth of the organisms, though with different relative potencies, and in some cases morphological changes were observed. However, there was no obvious correlation with the composition of the marker compounds, alkylamides, caffeic acid derivatives, and polysaccharides. L. donovani stimulated the production of the pro-inflammatory cytokines IL-6 and IL-8 in human bronchial epithelial cells and in human skin fibroblasts, but in both cases the standardized ethanol extract of E. purpurea (L.) Moench (Echinaforce) abolished the stimulation, indicating anti-inflammatory activity of this extract.
CONCLUSIONS: Thus various Echinacea extracts can inhibit the proliferation of these parasites and at least one can reverse the pro-inflammatory activity of Leishmania donovani.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20731557     DOI: 10.3109/13880200903483468

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  6 in total

1.  Effects of extracts from Echinacea purpurea (L) MOENCH on mice infected with different strains of Toxoplasma gondii.

Authors:  Arquimedes Gasparotto Junior; Maria Luiza Antonio Cosmo; Michelle de Paula Reis; Pamela Secundo Dos Santos; Daniela Dib Gonçalves; Francielly Mourão Gasparotto; Italmar Teodorico Navarro; Emerson Luiz Botelho Lourenço
Journal:  Parasitol Res       Date:  2016-06-09       Impact factor: 2.289

2.  Untargeted LC-MS metabolomic studies of Asteraceae species to discover inhibitors of Leishmania major dihydroorotate dehydrogenase.

Authors:  Lucas A Chibli; Annylory L Rosa; Maria Cristina Nonato; Fernando B Da Costa
Journal:  Metabolomics       Date:  2019-04-04       Impact factor: 4.290

3.  Bauer ketones 23 and 24 from Echinacea paradoxa var. paradoxa inhibit lipopolysaccharide-induced nitric oxide, prostaglandin E2 and cytokines in RAW264.7 mouse macrophages.

Authors:  Xiaozhu Zhang; Ludmila Rizshsky; Catherine Hauck; Luping Qu; Mark P Widrlechner; Basil J Nikolau; Patricia A Murphy; Diane F Birt
Journal:  Phytochemistry       Date:  2011-11-29       Impact factor: 4.072

4.  Echinacea purpurea (L.) Moench treatment of monocytes promotes tonic interferon signaling, increased innate immunity gene expression and DNA repeat hypermethylated silencing of endogenous retroviral sequences.

Authors:  Ken Declerck; Claudina Perez Novo; Lisa Grielens; Guy Van Camp; Andreas Suter; Wim Vanden Berghe
Journal:  BMC Complement Med Ther       Date:  2021-05-12

Review 5.  Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases.

Authors:  James B Hudson
Journal:  J Biomed Biotechnol       Date:  2011-10-26

6.  A systematic review on the effects of Echinacea supplementation on cytokine levels: Is there a role in COVID-19?

Authors:  Monique Aucoin; Valentina Cardozo; Meagan D McLaren; Anna Garber; Daniella Remy; Joy Baker; Adam Gratton; Mohammed Ali Kala; Sasha Monteiro; Cara Warder; Alessandra Perciballi; Kieran Cooley
Journal:  Metabol Open       Date:  2021-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.